COMPARATIVE EFFICIENCY OF THE COMBINED THERAPY IN PATIENT’S WITH ARTERIAL HYPERTENSION

Objective — to assess influence of the combined therapy on a functional condition endothelium, the central haemodynamics and geometry of heart in patients with hypertensive disease.

Subjects and methods. The volume of supervision has made 40 patients with arterial hypertension grade II hypertension, moderate — high
risk. Patients of the first group received the combined therapy lisinopril — 20 mg and hydrochlortiazid — 12.5 mg (iruzid — “Belupo”, Croatia), patients of the second group — therapy trandolapril and verapamil (tarka — “Ebbot”, Germany) — 2 and 180 mg accordingly.

Results. The combined therapy trandolapril and verapamil renders more expressed antihypertension effect, than lisinopril and hydrochlortiazid.
Appointment of the combined therapy promoted normalization morphofunctional heart indicators: in group of tarka ejection fraction
(EF) has authentically increased by 4.34 % (р = 0,02), the thickness to a back wall of the left ventricle has decreased for 5.8 % (р = 0,03) in group of iruzid. Also in both groups optimization functional a condition endothelium vessels as on level desquamation endotheliocytes, a function indicator endothelium and on a level of a factor of Willebrand was marked. Authentically more expressed positive influence on endothelium tarka in comparison with iruzid has been noticed.

Conclusion. At comparison of combinations fat-soluble ACE inhibitor with verapamil (tarka) and water-soluble ACE inhibitor in a combination with hydrochlortiazid (iruzid) the insignificant superiority of the first combination over the second for level of positive influence on endothelium of vessels has been revealed, more expressed antihypertensive effect and ability authentically to increase EF.

1. Российское медицинское общество по артериальной гипертонии (РМОАГ), Всероссийское научное общество кардиологов (ВНОК). Диагностика и лечение артериальной гипертензии. Российские рекомендации (четвертый пересмотр), 2010.

2. Дисфункция эндотелия и артериальная гипертензия. Под ред. П.А. Лебедева.Самара, 2010.

3. Зубарев М.А. Изометрическая стрессполикардиография в диагностике артериальной гипертензии, коронарной и сердечной недостаточности. Методические рекомендации для врачей и интернов. Пермь, 1995.

4. Mancia G., Laurent S., Agabiti-Rosei E., et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009;27:2121–58.

5. Колос И.П., Бойцов С.А. От комбинированной терапии к фиксированной комбинации. Русский медицинский журнал 2009;16(21):1445–57.

6. Преображенский Д.В., Сидоренко Б.А., Романова Н.Е., Шатунова И.М. Клиническая фармакология основных классов антигипертензивных препаратов. Consilium Med 2000;2(3):99–127.

7. Корзун А.И., Кириллова М.В. Сравнительная характеристика ингибиторов АПФ. СПб.: ВМедА, 2003.

8. MRFIT research group. Multiple Risk Factor Intervention Trial. Risk factor changes and mortality results. JAMA 1982;248:1465–77.

9. Wilhelmsen L., Berglund G., Elmfeldt D. et al. Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J Hypertens 1987;5:561–72.

10. Gerc V., Begovic B., Vehabovic M., et al. Effects of fixed combination of lisinopril plus hydrochlorothiazide on regression of left ventricular hypertrophy in patients with essential hypertension: an opened, multicentre, prospective clinical trial. Bosn J Basic Med Sci 2008;8(3):214–9.